Nanjing MeiRui Pharma Co. Ltd
http://www.meirui.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Nanjing MeiRui Pharma Co. Ltd
Deal Watch: Bristol Shores Up Cancer, NASH Pipelines With International Deals
Partnership with France’s Enterome will add a microbiome aspect to Bristol’s immuno-oncology efforts, while its license of Japanese firm Nitto Denko’s siRNA technology could bolster NASH combo therapy development. Meanwhile, Eagle moves into biosimilars with the purchase of Arsia for up to $78m.
Company Information
- Industry
- Pharmaceuticals
-
Medical Devices
- Monitoring Equipment & Devices
-
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
-
In Vitro Diagnostics
- Chemistry, Immunoassay
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nanjing MeiRui Pharma Co. Ltd
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice